6 days ago
2
ARTICLE AD BOX
Except North America which declined 13% YoY, Dr. Reddy's other business segments showed strong growth, adds the brokerage.
27 Oct 2025, 10:38 AM IST i 27 Oct 2025, 10:38 AM IST 27 Oct 2025, 10:38 AM IST
Dr. Reddy's Laboratories' India business revenue at Rs 15,780 million, was up by 13% YoY but down 7 % QoQ. (Photo: Envato)
Dr. Reddy's Q2 FY26 revenue, Rs 88,051 million, was up 10% YoY and 3% flat QoQ. Ebitda, at Rs 23,511 million, rose 3% YoY and QoQ. Ebitda margin stood at 26.7% and was down by 175 YoY and flat on a QoQ basis.
To continue reading this story
You must be an existing Premium User
Already a Premium User?
English (US) ·